search
Back to results

Proposal to Examine the Effect of Fecal Transplantation on Obesity

Primary Purpose

Disorientation as to People, Time and Place

Status
Unknown status
Phase
Not Applicable
Locations
Israel
Study Type
Interventional
Intervention
fecal material
normal saline
Sponsored by
Kaplan Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Disorientation as to People, Time and Place

Eligibility Criteria

40 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • healthy patients with a BMI of 30-40 kg/m2 who have a clear indication for a screening examination. These will be people who are above the age of 50 who have not had a screening colonoscopy in the last 10 years, or those with a family history of carcinoma of the colon who are over the age of 40 years.

Exclusion Criteria:

  • Exclusion criteria include hepatitis B and C infection,
  • consumption of more than 20 gram of alcohol per day,
  • diabetes mellitus treated with insulin,
  • previous unstable coronary artery disease in the last year,
  • HIV infection,
  • concomitant use of corticosteroids in the previous 3 months and severe diverticulosis.

If patients were to receive antibiotic therapy during the year of follow up of the study, data will only be included in the analysis prior to this time.

Sites / Locations

  • Kaplan Medical CenterRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Placebo Comparator

Active Comparator

Arm Label

placebo

intervention

Arm Description

250 ml of normal saline (sham transplantation).

250 ml of diluted fecal material prepared from a screened donor

Outcomes

Primary Outcome Measures

weight loss

Secondary Outcome Measures

Full Information

First Posted
January 8, 2015
Last Updated
January 12, 2015
Sponsor
Kaplan Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT02336789
Brief Title
Proposal to Examine the Effect of Fecal Transplantation on Obesity
Official Title
Proposal to Examine the Effect of Fecal Transplantation on Obesity.
Study Type
Interventional

2. Study Status

Record Verification Date
December 2014
Overall Recruitment Status
Unknown status
Study Start Date
December 2014 (undefined)
Primary Completion Date
December 2015 (Anticipated)
Study Completion Date
December 2016 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Kaplan Medical Center

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The investigators propose to transplant feces from thin, disease-free donors into obese patients undergoing colonoscopy for screening for colorectal carcinoma. The investigators will obtain feces from healthy donors with a BMI of between 21-24. The investigators will perform colonoscopy on healthy patients with a BMI of 30-40 kg/m2 who have a clear indication for a screening examination. All patients will undergo a screening colonoscopy and will be allocated to receive either 250 ml of diluted fecal material prepared from a screened donor, or an equivalent volume of normal saline (sham transplantation). The patients will be reviewed at 1 3 6 and 12 months. At this time note will be made of their weight, BMI and waist circumference. In addition note will be made of their fasting glucose and lipid profile.
Detailed Description
We propose to transplant feces from thin, disease-free donors into obese patients undergoing colonoscopy for screening for colorectal carcinoma. We will obtain feces from healthy donors with a BMI of between 21-24, in accordance with the Protocol that was approved by the Israel Ministry of Health. The stool sample will be prepared as detailed below : We will perform colonoscopy on healthy patients with a BMI of 30-40 kg/m2 who have a clear indication for a screening examination. These will be people who are above the age of 50 who have not had a screening colonoscopy in the last 10 years, or those with a family history of carcinoma of the colon who are over the age of 40 years. All patients will undergo a screening colonoscopy and will be allocated to receive either 250 ml of diluted fecal material prepared from a screened donor, or an equivalent volume of normal saline (sham transplantation). The material will be injected in the amount of 50 ml at five locations- the terminal ileum (or the cecum if the terminal ileum cannot be intubated), ascending colon, transverse colon, descending colon and sigmoid colon- during withdrawal of the colonoscope from the cecum. The stool will not be delivered to the endoscopy suite until the patient is sedated and only the endoscopist performing the procedure will know what treatment arm the patient is in. In addition, all patients participating in the study will receive standard advice regarding weight loss and physical activity (at least 90 minutes of walking for week) from a staff dietitian. Stool samples will be obtained from the donor( from the stool donated for transplantation) and the patients at baseline (prior to transplantation), 1 month and 12 months and frozen at -80 C for high throughput analysis by standard techniques. The patients will be reviewed at 1 3 6 and 12 months. At this time note will be made of their weight, BMI and waist circumference. In addition note will be made of their fasting glucose and lipid profile.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Disorientation as to People, Time and Place

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
20 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
placebo
Arm Type
Placebo Comparator
Arm Description
250 ml of normal saline (sham transplantation).
Arm Title
intervention
Arm Type
Active Comparator
Arm Description
250 ml of diluted fecal material prepared from a screened donor
Intervention Type
Other
Intervention Name(s)
fecal material
Intervention Description
. All patients will undergo a screening colonoscopy and will be allocated to receive either 250 ml of diluted fecal material prepared from a screened donor, or an equivalent volume of normal saline (sham transplantation).
Intervention Type
Other
Intervention Name(s)
normal saline
Intervention Description
All patients will undergo a screening colonoscopy and will be allocated to receive either 250 ml of diluted fecal material prepared from a screened donor, or an equivalent volume of normal saline (sham transplantation).
Primary Outcome Measure Information:
Title
weight loss
Time Frame
one year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: healthy patients with a BMI of 30-40 kg/m2 who have a clear indication for a screening examination. These will be people who are above the age of 50 who have not had a screening colonoscopy in the last 10 years, or those with a family history of carcinoma of the colon who are over the age of 40 years. Exclusion Criteria: Exclusion criteria include hepatitis B and C infection, consumption of more than 20 gram of alcohol per day, diabetes mellitus treated with insulin, previous unstable coronary artery disease in the last year, HIV infection, concomitant use of corticosteroids in the previous 3 months and severe diverticulosis. If patients were to receive antibiotic therapy during the year of follow up of the study, data will only be included in the analysis prior to this time.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ehud Melzer, MD
Phone
97289441846
Email
ehudm@clalit.org.il
First Name & Middle Initial & Last Name or Official Title & Degree
Stephen DH Malnick, MD
Phone
97289441371
Email
stephen@malnick.net
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Stephen DH Malnick, MD
Organizational Affiliation
Kaplan Medical Center
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Ehud Melzer, MD
Organizational Affiliation
Kaplan Medical Center
Official's Role
Study Director
Facility Information:
Facility Name
Kaplan Medical Center
City
Rehovot
ZIP/Postal Code
76100
Country
Israel
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ali Abdullah, MD
Phone
089441370

12. IPD Sharing Statement

Learn more about this trial

Proposal to Examine the Effect of Fecal Transplantation on Obesity

We'll reach out to this number within 24 hrs